NASDAQ:CEMP - Nasdaq - US15130J1097
2.325
+0.03 (+1.09%)
The current stock price of CEMP is 2.325 null. In the past month the price decreased by -26.77%. In the past year, price decreased by -69.21%.
Cempra Holdings, LLC is a pharmaceutical company engaged in developing antibiotics for the treatment of bacterial infectious diseases. It focuses on developing antibiotics for treating respiratory tract, skin and skin structure infections and to target the growing problem of antimicrobial resistance. Cempra Holdings, LLC is headquartered in Chapel Hill, North Carolina.
CEMPRA INC
6320 QUADRANGLE DRIVE SUITE 360
CHAPEL HILL NC 27517
CEO: David S. Zaccardelli
Phone: 919-313-6601
The current stock price of CEMP is 2.325 null. The price increased by 1.09% in the last trading session.
The exchange symbol of CEMPRA INC is CEMP and it is listed on the Nasdaq exchange.
CEMP stock is listed on the Nasdaq exchange.
CEMPRA INC (CEMP) has a market capitalization of 122.09M null. This makes CEMP a Micro Cap stock.
CEMPRA INC (CEMP) has a resistance level at 2.33. Check the full technical report for a detailed analysis of CEMP support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CEMP does not pay a dividend.
CEMPRA INC (CEMP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.47).
ChartMill assigns a fundamental rating of 4 / 10 to CEMP. CEMP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months CEMP reported a non-GAAP Earnings per Share(EPS) of -1.47. The EPS increased by 33.97% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -499.88% | ||
ROA | -42.78% | ||
ROE | -53.6% | ||
Debt/Equity | 0.03 |